EDITORIAL COMMENT

Abstract

Disparities in cancer care are well documented, reflecting differences in outcomes by race/ethnicity, sex/gender, and various social determinants of health. 1 Ward E Jemal A Cokkinides V et al. Cancer disparities by race/ethnicity and socioeconomic status. Ca-A Cancer J Clin. 2004; 54: 78-93 Crossref PubMed Scopus (1248) Google Scholar Among urologic malignancies, prostate cancer has been a glaring example for cancer disparities demonstrating higher disease incidence and mortality among men of African ancestry in the US. 2 Rodriguez R. Health care disparities in urologic oncology: a systematic review. Urology. 2019; Google Scholar However, disparities exist in bladder and kidney cancers as well. Higher rates of advanced bladder cancers are seen in women and higher bladder cancer-specific mortality rates have been observed among black patients. 2 Rodriguez R. Health care disparities in urologic oncology: a systematic review. Urology. 2019; Google Scholar Disentangling the drivers of disparities in urologic malignancies such as prostate cancer has proven to be challenging. In this issue of the gold journal, Rodriguez et al 2 Rodriguez R. Health care disparities in urologic oncology: a systematic review. Urology. 2019; Google Scholar provide a broad overview of biologic and clinical data available on both sex and racial/ethnic disparities in prostate, bladder, and kidney cancers.